methylprednisolone has been researched along with u 0126 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brdicka, T; Kalina, T; Kanderova, V; Skopcova, T; Svojgr, K; Zuna, J | 1 |
Beckmann, T; Boehncke, WH; Hänsel, M; Hellberg, L; Holdorf, K; Kirchner, T; Laskay, T; Ludwig, RJ; Möckel, N; Recke, A; Samavedam, UKSRL; Schmidt, E; Solbach, W; Steinhorst, K; Zillikens, D | 1 |
2 other study(ies) available for methylprednisolone and u 0126
Article | Year |
---|---|
The adaptor protein NTAL enhances proximal signaling and potentiates corticosteroid-induced apoptosis in T-ALL.
Topics: Adaptor Proteins, Signal Transducing; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Apoptosis; Butadienes; Drug Resistance, Neoplasm; Humans; In Vitro Techniques; Jurkat Cells; Lectins, C-Type; MAP Kinase Signaling System; Methylprednisolone; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasm Proteins; Nitriles; Phosphorylation; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Receptors, Antigen, T-Cell | 2012 |
Methylprednisolone blocks autoantibody-induced tissue damage in experimental models of bullous pemphigoid and epidermolysis bullosa acquisita through inhibition of neutrophil activation.
Topics: Adult; Animals; Antigen-Antibody Complex; Autoantibodies; Butadienes; Dermis; Disease Models, Animal; Enzyme Inhibitors; Epidermal Cells; Epidermis; Epidermolysis Bullosa Acquisita; Glucocorticoids; Humans; Imidazoles; MAP Kinase Signaling System; Methylprednisolone; Mice; Mice, Inbred C57BL; Neutrophils; Nitriles; Pemphigoid, Bullous; Pyridines; Reactive Oxygen Species; Respiratory Burst | 2013 |